Ticker Symbol: GMAB
Genmab - ADR
$41.13 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
Denmark
Currency:
USD
Asset
Type: ADR
CIK:0001434265
Company Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: http://www.genmab.com/
CEO: Jan van de Winkel
Tags:
- Health Technology
- Medical Specialties
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $34.11
Change:
-$0.12
(
-0.35%)
Days Range: $33.81 - $34.33
Beta: 0.66
52wk. High: $47.50
52wk. Low: $28.05
Ytd. Change -19.56%
50 Day Moving Average: $35.47
200 Day Moving Average: $38.40
Shares Outstanding: 660674810
Valuation
Market Cap: 2.3T
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A